Free tool
Rare disease stocks
We cover 89 companies grouped under the Rare disease theme. The median market value in the group is $483.48M. Across the group, the median move over the past trading day is −0.72%. 56% of the 85 with a 200-day average trade above it. Price change over the past year runs from −41.0% to +238.3% across the middle 80 percent of the group, with a median of +25.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
89 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.88B | Small cap | +5.54% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| 0L35.L | Sarepta Therapeutics, Inc. | $1.69B | Small cap | −0.06% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% |
| PYC.AX | PYC Therapeutics Limited | $1.60B | Small cap | +74.42% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +19.48% |
| 0LIF.L | Ultragenyx Pharmaceutical Inc. | $1.40B | Small cap | −13.39% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| 0HB0.L | Agios Pharmaceuticals, Inc. | $1.19B | Small cap | −13.00% |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −2.60% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| DBV.PA | DBV Technologies S.A. | $901.25M | Small cap | +60.13% |
| PHAR | Pharming Group N.V. | $845.80M | Small cap | −14.47% |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% |
| AGMB | AgomAb Therapeutics NV | $703.26M | Small cap | −2.53% |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% |
| VALN | Valneva SE | $634.84M | Small cap | −23.49% |
| AYJ.DE | Valneva SE | $619.77M | Small cap | −21.89% |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| 005257.KS | GC Corp. | $547.34M | Small cap | −40.16% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | $487.17M | Small cap | +43.78% |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% |
| QTTB | Q32 Bio Inc. | $481.67M | Small cap | +840.70% |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +6.92% |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | −1.42% |
| ENTA | Enanta Pharmaceuticals, Inc. | $412.12M | Small cap | +65.89% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $406.58M | Small cap | −9.63% |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% |
| IFRX | InflaRx N.V. | $356.63M | Small cap | +142.00% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | $338.48M | Small cap | −24.94% |
| PRQR | ProQR Therapeutics N.V. | $331.63M | Small cap | +6.33% |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +23.24% |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −41.78% |
| TTRX | Turn Therapeutics Inc. | $292.44M | Small cap | +37.57% |
| ELDN | Eledon Pharmaceuticals, Inc. | $272.22M | Small cap | +29.84% |
| IVVD | Invivyd, Inc. | $265.78M | Small cap | +3.52% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $263.56M | Small cap | +178.15% |
| SLGL | Sol-Gel Technologies Ltd. | $260.05M | Small cap | +261.87% |
| 0QN1.L | Santhera Pharmaceuticals Holding AG | $254.58M | Small cap | +11.86% |
| AKBA | Akebia Therapeutics, Inc. | $251.20M | Small cap | −69.88% |
| 0T6G.L | Q32 Bio Inc. | $246.69M | Small cap | — |
| PEPG | PepGen Inc. | $237.21M | Small cap | +159.68% |
| RNA | Prosensa Holding B.V. Ordinary Shares | $236.91M | Small cap | −6.10% |
| SIGA | SIGA Technologies, Inc. | $220.58M | Small cap | −57.93% |
| KROS | Keros Therapeutics, Inc. | $220.48M | Small cap | −28.35% |
| ANTX | AN2 Therapeutics, Inc. | $208.68M | Small cap | +385.09% |
| ARMP | Armata Pharmaceuticals, Inc. | $202.64M | Small cap | +123.36% |
| MSCL.TO | Satellos Bioscience Inc. | $199.95M | Small cap | +81.67% |
| PLX | Protalix BioTherapeutics, Inc. | $199.82M | Small cap | +55.00% |
| MSLE | Satellos Bioscience Inc. | $198.59M | Small cap | +77.27% |
| 0AB6.L | Hyloris Pharmaceuticals SA | $185.32M | Small cap | −33.23% |
| EQ | Equillium, Inc. | $149.64M | Small cap | +23.56% |
| AARD | Aardvark Therapeutics, Inc. | $149.04M | Small cap | −24.25% |
| UNCY | Unicycive Therapeutics, Inc. | $148.74M | Small cap | +27.17% |
| CRNO-B.ST | Cereno Scientific AB (publ) | $148.23M | Small cap | −53.59% |
| MIST | Milestone Pharmaceuticals Inc. | $146.91M | Small cap | −33.33% |
| 4599.T | StemRIM | $140.21M | Small cap | +14.75% |
| INO | Inovio Pharmaceuticals, Inc. | $134.42M | Small cap | −47.15% |
| DXB.AX | Dimerix Limited | $122.97M | Small cap | −34.83% |
| 0H8T.L | Aclaris Therapeutics, Inc. | $122.82M | Small cap | +237.38% |
| RFL | Rafael Holdings, Inc. | $119.08M | Small cap | +52.67% |
| MDP.TO | Medexus Pharmaceuticals Inc. | $117.29M | Small cap | +66.56% |
| PYPD | PolyPid Ltd. | $103.79M | Small cap | +49.42% |
| PTHS | Pelthos Therapeutics Inc. | $102.53M | Small cap | +12.90% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.